Abstract
The Latin American facial injectable market - comprising sales of botulinum
toxin, hyaluronic acid dermal fillers, particle and polymer fillers, and
collagen fillers - will grow steadily through 2014, driven by increased
patient demand and physician adoption of facial injectable treatments. Spurred
by high aesthetic consciousness, a rising number of people in Latin America
will demand convenient and effective cosmetic enhancements; this trend will be
particularly strong in Brazil, a country globally recognized for its cultural
emphasis on physical beauty. Physicians will also increasingly offer facial
injections to benefit from the profitability of these procedures, thereby
improving the availability of facial injectable treatments to patients. The
introduction of new products, as well as regulatory approval of existing ones,
will further drive market growth. Poor economic conditions due to the global
recession, however, have limited procedural growth in this market due to
declines in disposable incomes, and manufacturers have responded by offering
more discounted product bundles and rebates in order to stimulate product
sales; this will restrict average selling price growth to some extent through
2014.
| 
View Cart
